Gland Pharma Share Price
₹1863.00
as on
Gland Pharma Stock Performance
as on November 7, 2025 at 4:01 pm IST
Day's Low
Day's High
₹1,855.1₹1,897.5
0.42%
Downside
1.85%
Upside
52 Week's Low
52 Week's High
₹1,277.8₹2,13131.41%
Downside
14.39%
Upside
Gland Pharma share price movements today
- Previous Close
- ₹1,898.60
- Open
- ₹1,895.00
- Volume
- 1.11L
- Upper Circuit
- ₹2,278.30
- Lower Circuit
- ₹1,518.90
- Day's Low - High
- ₹1,855.1 - ₹1,897.5
- 52 Week Low - High
- ₹1,277.8 - ₹2,131
Gland Pharma Historical Returns
- 1 Month Return
- -4.8 %
- 3 Month Return
- -3.7 %
- 1 Year Return
- + 4.8 %
- 3 Year Return
- + 5.16 %
- 5 Year Return
- + 2.39 %
Gland Pharma Fundamentals
as on November 7, 2025 at 4:01 pm IST
Market Cap
₹30,694.12 Cr
Return on Equity (ROE)
11.62
PE Ratio (TTM)
38.84
Return on capital employed (ROCE)
15.83
Industry PE ratio
41.8
Beta (LTM)
0.71
P/B Ratio
2.69
Dividend Yield
1.13
PEG Ratio
6.49
Quarterly Earnings Growth YOY
12.32
EPS (TTM)
42.4
Sector
Pharmaceuticals
Book Value
555.4
Technical Analysis
Bearish
View Technical Analysis
Gland Pharma Stock Valuation
as on November 7, 2025 at 4:01 pm IST
Gland Pharma in the last 5 years
Lowest (18.84x)
May 22, 2023
Today (38.84x)
November 7, 2025
Industry (41.80x)
November 7, 2025
Highest (67.14x)
August 12, 2021
Today’s Price to Earnings Ratio: 38.84x
Gland Pharma Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Gland Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 30,694.12 | 0.48% | 0.53 | 698 | 5,616 | |
| HOLD | 1,76,709.16 | 18.88% | 0.50 | 2,191 | 9,360 | |
| BUY | 1,21,158.03 | 36.11% | 0.66 | 1,911 | 11,516 | |
| BUY | 50,858.10 | -1.71% | 0.78 | 1,429 | 15,261 | |
| BUY | 1,21,626.11 | 19.46% | 0.51 | 5,291 | 27,547 |
Analyst Recommendation on Gland Pharma Stock
Based on 11 analysts
45.45%
Buy
18.18%
Hold
36.36%
Sell
Based on 11 analysts, 45.45% of analysts recommend a 'HOLD' rating for Gland Pharma. Average target price of ₹1938.18
Source: S&P Global Market Intelligence
Gland Pharma Share Price Target
Get share price movements and forecasts by analysts on Gland Pharma.
What analysts predicted
4.04%UPSIDE
Target Price
₹1938.18
Current Price
₹1863
Analyzed by
11 Analysts
High
₹2340
Target
₹1938.18
Low
₹1630
Gland Pharma target price ₹1938.18, a slight upside of 4.04% compared to current price of ₹1863. According to 11 analysts rating.
Source: S&P Global Market Intelligence
Gland Pharma Stock’s Investor Sentiment and Interest
Search interest for Gland Pharma Ltd Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Gland Pharma Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Gland Pharma Ltd Annual Profit & Loss
Figures in Rupees Crores
Gland Pharma Ltd Cash Flow
Figures in Rupees Crores
Gland Pharma Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Gland Pharma Stock
Check out the Mutual Funds with significant holdings in Gland Pharma.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 HDFC Mid Cap Fund -Direct Plan - Growth Option | 1.38% | 5860179 | |
 SBI Large & Midcap Fund Direct Growth | 1.85% | 3170000 | |
 Mirae Asset Large & Midcap Fund Direct Plan Growth | 1.42% | 2905998 | |
 Nippon India Growth Mid Cap Fund - Direct Plan - Growth Mid Cap | 1.42% | 2800000 | |
 ICICI Prudential India Opportunities Fund Direct Growth | 1.46% | 2251077 |
Gland Pharma Corporate Actions
View detailed summary of the earnings and dividend history of Gland Pharma.
Gland Pharma Ltd Earnings Results
Gland Pharma Ltd’s net profit jumped 12.32% since last year same period to ₹183.68Cr in the Q2 2025-2026. On a quarterly growth basis, Gland Pharma Ltd has generated -14.76% fall in its net profits since last 3-months.
Read More about Earnings ResultsGland Pharma Ltd Dividends May,2025
In the quarter ending March 2025, Gland Pharma Ltd has declared dividend of ₹18.00 per share on 20 May 2025 - translating a dividend yield of 2.04%.
Read More about Dividends
Indices Featuring Gland Pharma Stock
Check stock indices that include Gland Pharma.
Insights on Gland Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 7.39% to 7.91% in Sep 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 1.44K Cr → 1.57K Cr (in ₹), with an average increase of 2.8% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, GLAND stock has moved up by 35.2%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 51.83% of holdings in Sep 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 15.5% return, outperforming this stock by 10.2%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 111.3% return, outperforming this stock by 106.2%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 30.67% to 30.19% in Sep 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 7.93% to 7.63% in Sep 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 215.48 Cr → 183.68 Cr (in ₹), with an average decrease of 14.8% per quarter
About Gland Pharma Ltd
Gland Pharma's operations include the development, manufacture, and marketing of a wide range of injectable drugs and active pharmaceutical ingredients. The company's product portfolio includes antibiotics, anti-emetics, anti-diabetics, anti-epileptics, and other therapeutic categories. Its top products include cephalosporins, penicillins, and other injectable antibiotics.
Gland Pharma is well known for its popular brands, such as Cephalosporin, Penicillin, and Amikacin. These brands have been widely used in hospitals and clinics across India, as well as in other countries. In addition, the company has developed and launched a wide range of generic and branded injectables, including Cefazolin, Cefuroxime, and Amikacin.
Revenue: ₹1,486.88Cr as on September 2025 (Q2 FY26)
Net Profit: ₹183.68Cr as on September 2025 (Q2 FY26)
Listing date: 20 Nov, 2020
Chairperson Name: Yiu Kwan Stanley Lau
| Organisation | Gland Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Yiu Kwan Stanley Lau |
| E-voting on shares | Click here to vote |
FAQs
What is Gland Pharma share price today?
Gland Pharma share price today stands at ₹1863 as on at the close of the market. Gland Pharma share today touched a day high of ₹1897.5 and a low of ₹1855.1.
What is the 52 week high and 52 week low range for Gland Pharma share?
Gland Pharma touched a 52 week high of ₹2131 and a 52 week low of ₹1277.8. Gland Pharma share price today i.e. is closed at ₹1863, which is -12.58% down from its 52 week high and 45.80% up from its 52 week low.
What is Gland Pharma's market capitalisation today?
Gland Pharma market capitalisation is ₹30,694.12 Cr as on .
How to buy Gland Pharma shares?
To buy Gland Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for GLAND or Gland Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Gland Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Gland Pharma trading volume today?
Gland Pharma trading volume is 1.11L as on . This means that 1.11L shares of Gland Pharma were bought and sold on the stock market during today's trading session.